1. Home
  2. News
  3. Goldline Pharmaceutical Ltd.
  4. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
More Goldline Pharmaceutical Ltd. news
GO Goldline Pharmaceutical Ltd.BSE: GLPL

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Aug 29, 2026 at 7:34 AM EDT · Issued by Goldline Pharmaceutical Ltd. via BSE India

Filed with BSE · Aug 29, 2026 at 7:34 AM EDT · 4 pages · English

On 6ix: 6ix.com/news/disclosures-under-reg-292-of-sebi-sast-regulations-2011-84

Goldline Pharmaceutical Ltd. on 6ix

Earlier from Goldline Pharmaceutical

  • Goldline Pharmaceutical Ltd. Press Release Aug 07 2026Aug 7
  • Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 7
  • Goldline Pharmaceutical Ltd. Press Release Jul 30 2026Jul 29
  • Goldline Pharmaceutical Ltd. Press Release Jul 20 2026Jul 20
  • Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 20

Later from Goldline Pharmaceutical

  • Goldline Pharmaceutical Ltd. Press Release Aug 29 2026Aug 29
  • Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29
  • Goldline Pharmaceutical Ltd. Press Release Aug 31 2026Aug 31
  • Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 31
  • Goldline Pharmaceutical Ltd. Press Release Sep 01 2026Sep 1
All Goldline Pharmaceutical news releases↗

Follow Goldline Pharmaceutical into a list and get an email when it puts out news.

Follow Goldline Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer